Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980 Oct;70(2):307–311. doi: 10.1111/j.1476-5381.1980.tb07937.x

The activity of sodium cromoglycate analogues in human lung in vitro: a comparison with rat passive cutaneous anaphylaxis and clinical efficacy.

M K Church, C F Gradidge
PMCID: PMC2044331  PMID: 6159030

Abstract

1 Eleven analogues of sodium cromoglycate have been tested for their ability to suppress histamine release induced by anti-IgE from passively sensitized human lung fragments in vitro. 2 With the exception of WY 16922, which released histamine at high concentrations, all inhibited histamine release in a linear dose-related manner. 3 The analogues were 30 to 1500 times more potent than sodium cromoglycate. However, their regression slopes of activity upon log-concentration were only one-third as steep as that for sodium cromoglycate, indicating a possible difference in their mechanism of action. 4 In comparison with sodium cromoglycate, the analogues were more potent in human lung than in rat passive cutaneous anaphylaxis (PCA); there was no quantitative correlation between potencies in the two tests. 5 The human lung model is not predictive of anti-asthmatic activity in man as the six analogues tested clinically are less effective than sodium cromoglycate. 6 These results throw doubt on the use of models of mast cell degranulation in the search for anti-allergic drugs and, possibly, on the relative importance of mast cell degranulation in the pathogenesis of asthma.

Full text

PDF
307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assem E. S., Evans J. A., McAllen M. Inhibition of experimental asthma in man by a new drug (AH 7725) active when given by mouth. Br Med J. 1974 Apr 13;2(5910):93–95. doi: 10.1136/bmj.2.5910.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Augstein J., Cairns H., Hunter D., Lee T. B., Suschitzky J., Altounyan R. E., Jackson D. M., Mann J., Orr T. S., Sheard P. New orally effective chromosome derivatives for the treatment of asthma. Agents Actions. 1977 Oct;7(4):443–445. doi: 10.1007/BF01966850. [DOI] [PubMed] [Google Scholar]
  3. Batchelor J. F., Follenfant M. J., Garland L. G., Gorvin J. H., Green A. F., Hodson H. F., Hughes D. T., Tateson J. E. Doxantrazole, an antiallergic agent orally effective in man. Lancet. 1975 May 24;1(7917):1169–1170. doi: 10.1016/s0140-6736(75)93141-4. [DOI] [PubMed] [Google Scholar]
  4. Brogden R. N., Speight T. M., Avery G. S. Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use. Drugs. 1974;7(3):164–282. doi: 10.2165/00003495-197407030-00002. [DOI] [PubMed] [Google Scholar]
  5. Broughton B. J., Chaplen P., Knowles P., Lunt E., Pain D. L., Wooldridge K. R., Ford R., Marshall S., Walker J. L., Maxwell D. R. New inhibitor of reagin-mediated anaphylaxis. Nature. 1974 Oct 18;251(5476):650–652. doi: 10.1038/251650a0. [DOI] [PubMed] [Google Scholar]
  6. Church M. K., Gradidge C. F. Potentiation of histamine release by sodium cromoglycate. Life Sci. 1978 Nov 9;23(19):1899–1903. doi: 10.1016/0024-3205(78)90555-6. [DOI] [PubMed] [Google Scholar]
  7. Coulson C. J., Ford R. E., Marshall S., Walker J. L., Wooldridge K. R., Bowden K., Coombs T. J. Interrelationship of cyclic nucleotides and anaphylactic reactions. Nature. 1977 Feb 10;265(5594):545–547. doi: 10.1038/265545a0. [DOI] [PubMed] [Google Scholar]
  8. Cox J. S., Beach J. E., Blair A. M., Clarke A. J., King J., Lee T. B., Loveday D. E., Moss G. F., Orr T. S., Ritchie J. T. Disodium cromoglycate (Intal). Adv Drug Res. 1970;5:115–196. [PubMed] [Google Scholar]
  9. El-Azab J., Stewart P. B. Pharmacologic profile of a new antiallergic compound PRD-92-Ea. Int Arch Allergy Appl Immunol. 1977;55(1-6):350–361. doi: 10.1159/000231946. [DOI] [PubMed] [Google Scholar]
  10. Evans D. P., Lewis J. A., Thomson D. S. An automated fluorimetric assay for the rapid determination of histamine in biological fluids. Life Sci II. 1973 Apr 8;12(7):327–336. doi: 10.1016/0024-3205(73)90366-4. [DOI] [PubMed] [Google Scholar]
  11. Evans D. P., Thomson D. S. Inhibition of immediate hypersensitivity reactions in laboratory animals by a phenanthroline salt (ICI 74,917). Br J Pharmacol. 1975 Mar;53(3):409–418. doi: 10.1111/j.1476-5381.1975.tb07377.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fullarton J., Martin L. E., Vardey C. Studies on the inhibition of cellular anaphylaxis. Int Arch Allergy Appl Immunol. 1973;45(1):84–86. doi: 10.1159/000231007. [DOI] [PubMed] [Google Scholar]
  13. Goose J., Blair A. M. Passive cutaneous anaphylaxis in the rat, induced with two homologous reagin-like antibodies and its specific inhibition with disodium cromoglycate. Immunology. 1969 Jun;16(6):749–760. [PMC free article] [PubMed] [Google Scholar]
  14. Gribbin H. R., Harvey J. E., Tattersfield A. E. Trial of doxantrazole in asthma. Br Med J. 1979 Jan 13;1(6156):92–92. doi: 10.1136/bmj.1.6156.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Miller P., James G. W. Inhibition of experimental immediate hypersensitivity reactions by a novel xanthone, RU 31156. Arch Int Pharmacodyn Ther. 1978 Feb;231(2):328–339. [PubMed] [Google Scholar]
  16. Moxham J., McAllen M. A controlled clinical trial comparing disodium cromoglycate and ICI 74,917 in extrinsic asthma. Clin Allergy. 1979 Jan;9(1):61–64. doi: 10.1111/j.1365-2222.1979.tb01523.x. [DOI] [PubMed] [Google Scholar]
  17. Muittari A., Ahonen A., Kellomäki L., Kuusisto P., Lehtinen J., Veneskoski T. The effect of ICI 74,917 on asthma and bronchial provocation tests. Clin Allergy. 1978 May;8(3):281–288. doi: 10.1111/j.1365-2222.1978.tb03225.x. [DOI] [PubMed] [Google Scholar]
  18. Pauwels R., Lamont H., Van der Straeten M. The protective effect of inhaled BRL 10833 on allergen induced bronchospasm. Clin Allergy. 1976 Sep;6(5):463–469. doi: 10.1111/j.1365-2222.1976.tb01930.x. [DOI] [PubMed] [Google Scholar]
  19. Poppius H., Stenius B. Exercise-induced asthma and doxantrazole. Eur J Clin Pharmacol. 1977 Jan 3;11(2):107–109. doi: 10.1007/BF00562900. [DOI] [PubMed] [Google Scholar]
  20. Rosenthale M. E., Begany A. J., Dervinis A., Sellstedt J., Guinosso C., Gluckman M. I. Immunopharmacologic properties of WY-16, 922, a new orally effective antiallergic agent. J Pharmacol Exp Ther. 1976 Jun;197(3):725–733. [PubMed] [Google Scholar]
  21. Sharpe T. J., Ross J. W., Spicer B. A. The effect of sodium 5,6-dimethyl-2-nitroindanedione on anaphylactic reactions in vitro. Agents Actions. 1978 Apr;8(3):199–202. doi: 10.1007/BF01966603. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES